JCI vs NMRA · P/E 44, rev $23.60B vs $283.5M cap
Johnson Controls International PLC (JCI) versus Neumora Therapeutics, Inc. (NMRA) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
NMRA does not have a complete income-statement cache yet.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. NMRA currently screens at market cap $283.5M.
Not investment advice. Open the JCI and NMRA stock pages for the full models.
Not investment advice.